Literature DB >> 15630073

Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil.

Andreas Heinz1, Matthias Reimold, Jana Wrase, Derik Hermann, Bernhard Croissant, Götz Mundle, Bernhard M Dohmen, Dieter F Braus, Dieter H Braus, Gunter Schumann, Hans-Jürgen Machulla, Roland Bares, Karl Mann.   

Abstract

BACKGROUND: The pleasant effects of food and alcohol intake are partially mediated by mu-opiate receptors in the ventral striatum, a central area of the brain reward system. Blockade of mu-opiate receptors with naltrexone reduces the relapse risk among some but not all alcoholic individuals.
OBJECTIVE: To test the hypothesis that alcohol craving is pronounced among alcoholic individuals with a high availability of mu-opiate receptors in the brain reward system.
DESIGN: Patients and comparison sample. The availability of central mu-opiate receptors was measured in vivo with positron emission tomography (PET) and the radioligand carbon 11-labeled carfentanil in the ventral striatum and compared with the severity of alcohol craving as assessed by the Obsessive Compulsive Drinking Scale (OCDS).
SETTING: Hospitalized care. PARTICIPANTS: Volunteer sample of 25 male alcohol-dependent inpatients assessed after detoxification of whom 12 underwent PET again 5 weeks later. Control group of 10 healthy men. MAIN OUTCOME MEASURES: After 1 to 3 weeks of abstinence, the availability of mu-opiate receptors in the ventral striatum, including the nucleus accumbens, was significantly elevated in alcoholic patients compared with healthy controls and remained elevated when 12 alcoholic patients had these levels measured 5 weeks later (P<.05 corrected for multiple testing). Higher availability of mu-opiate receptors in this brain area correlated significantly with the intensity of alcohol craving as assessed by the OCDS.
CONCLUSIONS: Abstinent alcoholic patients displayed an increase in mu-opiate receptors in the ventral striatum, including the nucleus accumbens, which correlated with the severity of alcohol craving. These findings point to a neuronal correlate of alcohol urges.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15630073     DOI: 10.1001/archpsyc.62.1.57

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  62 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

Review 2.  [Cue-induced alcohol craving. Neurobiological correlates and clinical relevance].

Authors:  J Wrase; S M Grüsser; A Heinz
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

Review 3.  Targeted opioid receptor antagonists in the treatment of alcohol use disorders.

Authors:  Mark J Niciu; Albert J Arias
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

Review 4.  Addiction: the clinical interface.

Authors:  D Nutt; A Lingford-Hughes
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

5.  Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability.

Authors:  Tomi Karjalainen; Lauri Tuominen; Sandra Manninen; Kari K Kalliokoski; Pirjo Nuutila; Iiro P Jääskeläinen; Riitta Hari; Mikko Sams; Lauri Nummenmaa
Journal:  Soc Cogn Affect Neurosci       Date:  2016-04-06       Impact factor: 3.436

6.  Association between Opioid Receptor mu 1 (OPRM1) Gene Polymorphisms and Tobacco and Alcohol Consumption in a Spanish Population.

Authors:  Francesc Francès; Olga Portolés; Ana Castelló; Jose Antonio Costa; Fernando Verdú
Journal:  Bosn J Basic Med Sci       Date:  2015-04-25       Impact factor: 3.363

Review 7.  [Nalmefene: a novel pharmacotherapeutic option for alcoholism].

Authors:  M Soyka
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

8.  Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.

Authors:  Elise M Weerts; Gary S Wand; Hiroto Kuwabara; Xiaoqiang Xu; J James Frost; Dean F Wong; Mary E McCaul
Journal:  Addict Biol       Date:  2012-12-18       Impact factor: 4.280

Review 9.  Identifying the neural circuitry of alcohol craving and relapse vulnerability.

Authors:  Andreas Heinz; Anne Beck; Sabine M Grüsser; Anthony A Grace; Jana Wrase
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

10.  Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence.

Authors:  James C Garbutt; Michael Osborne; Robert Gallop; John Barkenbus; Kathy Grace; Meghan Cody; Barbara Flannery; Alexey B Kampov-Polevoy
Journal:  Alcohol Alcohol       Date:  2009-02-03       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.